Electromyographic-biofeedback (EMG-BFB) efficacy for treatment of juvenile tension-type headache: Results at 2 years follow-up

Licia Grazzi, Gennaro Bussone

Research output: Contribution to journalArticlepeer-review


Biofeedback is an excellent therapeutic alternative instead of pharmacological treatment for children suffering from tension-type headache; its clinical efficacy has to be confirmed by considering control groups and following patients long-term to exclude the possibility of a placebo effect. Twenty-five patients (mean age 11.4 ± 2.4), suffering from tension-type headache, were treated by BFB for ten sessions. Follow-ups were fixed at 1 and 2 years after treatment. A significant decrease of Pain Total Index was observed at the 1-year follow-up and also at the 2-year follow-up (PTI pre 175 ± 130 vs. PTI 1 year 27.7 ± 37.7 vs. PTI 2 years 50 ± 77.8; pre vs. 1 year p <.0001; pre vs. 2 years p <.0001; 1 year vs. 2 years ns). These results seem to confirm the real efficacy of the behavioral approach and contribute to showing that BFB is an optimum alternative to pharmacological treatment, particularly in pediatric practice.

Original languageEnglish
Pages (from-to)370
Number of pages1
JournalBiofeedback and Self-Regulation
Issue number4
Publication statusPublished - 1996


  • EMG-biofeedback treatment
  • Juvenile tension-type headache
  • Long-term clinical follow-up

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)


Dive into the research topics of 'Electromyographic-biofeedback (EMG-BFB) efficacy for treatment of juvenile tension-type headache: Results at 2 years follow-up'. Together they form a unique fingerprint.

Cite this